ConductScience.org, home

Paper37397495

Design, in silico and pharmacological evaluation of a peptide inhibitor of BACE-1.

Boldin R and 3 others. Front Pharmacol, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Design, in silico and pharmacological evaluation of a peptide inhibitor of BACE-1. Papers, record 37397495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37397495

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design, in silico and pharmacological evaluation of a peptide inhibitor of BACE-1.
PubMed
Journal
Front Pharmacol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.15
iCite
Revised in PubMed
2023-07-04
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boldin RRenata
2Zychar BCBianca Cestari
3Gonçalves LRCLuis Roberto C
4Sciani JMJuliana Mozer

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131724512Neuroprotective Effect of β-secretase Inhibitory Peptide from Pacific Hake (Merluccius productus) Fish Protein Hydrolysate.Curr Alzheimer Res2019https://conductscience.org/library/papers/31724512PubMed
231753135Alzheimer's disease.Handb Clin Neurol2019https://conductscience.org/library/papers/31753135PubMed
312130773The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.Science2002https://conductscience.org/library/papers/12130773PubMed
430368849MDockPeP: An ab-initio protein-peptide docking server.J Comput Chem2018https://conductscience.org/library/papers/30368849PubMed
520061647Alzheimer's disease and the amyloid-beta peptide.J Alzheimers Dis2010https://conductscience.org/library/papers/20061647PubMed
635165272Therapeutic peptides: current applications and future directions.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35165272PubMed
734765995Developing inhaled protein therapeutics for lung diseases.Mol Biomed2020https://conductscience.org/library/papers/34765995PubMed
830132264Biodistribution and Pharmacokinetics of Amblyomin-X, a Novel Antitumour Protein Drug in Healthy Mice.Eur J Drug Metab Pharmacokinet2019https://conductscience.org/library/papers/30132264PubMed
924228993Basics and recent advances in peptide and protein drug delivery.Ther Deliv2013https://conductscience.org/library/papers/24228993PubMed
1022122681Developing β-secretase inhibitors for treatment of Alzheimer's disease.J Neurochem2012https://conductscience.org/library/papers/22122681PubMed
1134458730The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study.Brain Commun2021https://conductscience.org/library/papers/34458730PubMed
1224556009Targeting the β secretase BACE1 for Alzheimer's disease therapy.Lancet Neurol2014https://conductscience.org/library/papers/24556009PubMed
1335493943Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab.Front Aging Neurosci2022https://conductscience.org/library/papers/35493943PubMed
1426344955Bioactive peptides of animal origin: a review.J Food Sci Technol2015https://conductscience.org/library/papers/26344955PubMed
1535620224Biochemical and Toxinological Characterization of Venom from Macrorhynchia philippina (Cnidaria, Hydrozoa).Biomed Res Int2022https://conductscience.org/library/papers/35620224PubMed
1618697993Presenilins: members of the gamma-secretase quartets, but part-time soloists too.Physiology (Bethesda)2008https://conductscience.org/library/papers/18697993PubMed
1722194329Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations.Acta Crystallogr D Biol Crystallogr2012https://conductscience.org/library/papers/22194329PubMed
1815837590Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.Neurobiol Dis2005https://conductscience.org/library/papers/15837590PubMed
1927152113Initial peptidomic profiling of Brazilian sea urchins: Arbacia lixula, Lytechinus variegatus and Echinometra lucunter.J Venom Anim Toxins Incl Trop Dis2016https://conductscience.org/library/papers/27152113PubMed
2028604595Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.Int J Mol Sci2017https://conductscience.org/library/papers/28604595PubMed

See all 36 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42357312Putatively Identified Sarmentoside-B Removes Oligomerized Amyloid Peptide from Neurons by Inhibiting mTOR and Restoring Lysosomal Function, in In Vitro Alzheimer's Disease Model.Pharmaceutics2026https://conductscience.org/library/papers/42357312PubMed
42032388Natural compounds from Fernandoa adenophylla (Wall. ex G.Don) Steenis as beta-secretase 1 and monoamine oxidase-b inhibitors: in vitro and computational evidence.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42032388PubMed
41685658A Review of Current Computational Tools for Peptide-Protein Docking.J Comput Chem2026https://conductscience.org/library/papers/41685658PubMed
40908696Precision Enzyme: Targeted Drug Discovery in Neurodegenerative Disorders.Protein Pept Lett2025https://conductscience.org/library/papers/40908696PubMed
38561605A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides.Curr Protein Pept Sci2024https://conductscience.org/library/papers/38561605PubMed
38317814γ-Secretase Inhibitors Selected by Molecular Docking, to Develop a New Drug Against Alzheimer's Disease.Rep Biochem Mol Biol2023https://conductscience.org/library/papers/38317814PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
BACE123621PubTator's text mininghttps://conductscience.org/library/genes/23621NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37397495

GET https://conductscience.org/api/papers/v1/37397495/references?page=2